Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device

Journal of the American College of Cardiology

Volumn 27, Issue 4, 1996, Pages 894-901

  Nakatani, Satoshi ^a   McCarthy, Patrick M ^a   Kottke Marchant, Kandice ^a   Harasaki, Hiroaki ^a   James, Karen B ^a   Savage, Robert M ^a   Thomas, James D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0029867928     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00555-2     Document Type: Article

References (29)

1. Evans RW, Manninen DL, Garrison LP Jr, Maier AM. Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986;255:1892-8.
2. Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives. Heart Transplants: Concerns About Cost, Access, and Availability of Donor Organs. Washington, D.C.: U.S. General Accounting Office, 1989.
3. Stevenson LW, Warner SL, Steimle AE, et al. The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection. Circulation 1994;89:450-7.
4. McCarthy PM, Portner PM, Tobler HG, Starnes VA, Ramasamy N, Oyer PE. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg 1991;102:578-87.
5. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate® 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080-90.
6. Burton NA, Lefrak EA, Macmanus Q, et al. A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Ann Thorac Surg 1993;55:1425-31.
7. Champsaur G, Ninet J, Vigneron M, Cochet P, Neidecker J, Boissonnat P. Use of the Abiomed BVS System 5000 as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1990;10:122-8.
8. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Surg 1994;6:174-80.
9. Lick S, Copeland JG, Rosado LJ, Sethi G, Smith RG, Cleavinger M. Long-term bridge to transplantation with the Symbion acute ventricular assist device system. Ann Thorac Surg 1991;52:308-9.
10. Dasse KA, Frazier H, Lesniak JM, Myers T, Burnett CM, Poirier VL. Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J 1992;38:M622-6.
11. Scheinin SA, Capek P, Radovancevic B, Duncan JM, McAllister HA Jr, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 1992; 38:M271-4.
12. Phillips WS, Burton NA, Macmanus Q, Lefrak EA. Surgical complications in bridging to transplantation: the Thermo Cardiosystems LVAD. Ann Thorac Surg 1992;53:482-6.
13. Drexler M, Erbel R, Müller U, Wittlich N, Mohr-Kahaly S, Meyer J. Measurement of intracardiac dimensions and structures in normal young adult subjects by transesophageal echocardiography. Am J Cardiol 1990;65: 1491-6.
14. Stoddard MF, Liddell NE, Vogel RL, Longaker RA, Dawkins PR. Comparison of cardiac dimension by transesophageal and transthoracic echocardiography. Am Heart J 1992;124:675-8.
15. Schoen FJ. Interventional and surgical cardiovascular pathology. Philadelphia: WB Saunders, 1989:369-96.
16. Tamanek RJ, Pavis JW, Anderoon SC. The effects of alpha-methyl dopa on cardiac hypertrophy in spontaneously hypertensive rats: ultrastructural, stereologic and morphometric analysis. Cardiovasc Res 1979;13:173.
17. Sommer JR, Johnson EA. Ultrastructure of cardiac muscle. In: Berne RM, Sperelakis N, Geiger SR, editors. Handbook of Physiology. Section 2. The Cardiovascular System. Baltimore: Williams & Wilkins, 1979:113-86.
18. Di Segni E, Beker B, Arbel Y, et al. Left ventricular pseudohypertrophy in pericardial effusion as a sign of cardiac tamponade. Am J Cardiol 1990;66: 508-11.
19. Spotnitz HM, Spotnitz WD, Cottrell TS, Spiro D, Sonnenblick EH. Cellular basis for volume related wall thickness changes in the rat left ventricle. J Mol Cell Cardiol 1974;6:317-31.
20. Di Segni E, Feinberg MS, Sheinowitz M, et al. Left ventricular pseudohypertrophy in cardiac tamponade: an echocardiographic study in a canine model. J Am Coll Cardiol 1993;21:1286-94.
21. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 1988;78:186-201.
22. Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 1990;67:23-34.
23. Beltrami CA, Finanto N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-63.
24. Harasaki H, Zheng Z, Morimoto T, McMahon J, Golding L, Nose Y. Morphometric studies of chronic fibrillating heart. Trans Am Soc Artif Intern Organs 1985;31:73-8.
25. Kinoshita M, Takano H, Taenaka Y, et al. Cardiac disuse atrophy during LVAD pumping. ASAIO Trans 1988;34:208-12.
26. Thompson EW, Marino TA, Uboh CE, Kent RL, Cooper G. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res 1984;54:367-77.
27. Unverferth DV. Gross and light microscopic findings in dilated cardiomyopathy. In: Unverferth DV, ed. Dilated Cardiomyopathy. New York: Futura, 1985:17-42.
28. Holman WL, Bourge RC, Kirklin JK. Case report: circulatory support for seventy days with resolution of acute heart failure [letter]. J Thorac Cardiovasc Surg 1991;102:932-4.
29. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 1994;89:2908-14.